Breast cancer cure rates almost doubled in combo therapy trial | A phase 3 clinical trial has shown that adding a targeted immunotherapy drug to chemotherapy dramatically improved the cure rate for patients with the most common kind of breast cancer.

https://ift.tt/TP5UdVj via /r/tech https://ift.tt/oTuWCZr